Skip to content

PHARMACIE BEULS

Active
Public limited companyfounded 1987active for 38 yearsDorpstraat(L) 7, 7700 Mouscron, BelgiumKBO/BCE: BE 0432.602.380
Summary

PHARMACIE BEULS has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €115,781 and a net result of €35,617. Equity has been stable since 2018 (±0.6% per year). Its solvency ranks better than 19% of 5,039 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Official details

Source: KBO
Status
Active since 23-11-1987 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.032.072.202 7700 Mouscron, since 17-12-1987
Financial year end
31 December
Peppol
Reachable since 25-09-2025

Board and ownership

Board
Shareholders

Financial position

85 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Annual accounts 2025
Gross margin
€216,282
▼ 6.6%
Turnover
≈ €1.0m
estimated
Profit
€35,617
▼ 41.5%
Equity
€115,781
▲ 1.4%
Total assets
€1.4m
▲ 2.5%
Employees on 31-12-2025
3
=
Score breakdownraises riskEquity €115,781 (8.0% of total assets)Sector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.06, cash €602,478Founded in 1987Show the evidence

Checked score

Score 2025
85 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 44% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency 33=
equity 8.0% of total assets
Liquidity 50=
short-term debt 92.0% · cash 41.6%
Profitability 72-2
return on assets 2.5%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025lowest value 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.3%▼ -0.1 percentage points vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026 11-2026: 0.3%● unchanged vs 10-2026
Credit of up to €9,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.06 (1.06 in 2024), below the usual 1.5. Short-term debt is 92% and cash 41.6% of total assets. 92% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 25% of them on solvency, 52% on liquidity, 55% on profitability and 44% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €115,781 (8.0% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Liquidity: current ratio 1.06, cash €602,478
NBB · annual accounts
lowers risk · Founded in 1987
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 5039 sector peers (2025).
NBB · sector comparison
Position among 5039 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-06-2026, 49 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
49 days early
2024
13 days early
2023
12 days early
2022
18 days early
2021
20 days early
2020
19 days early
2019
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 15 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 81% of companies in retail tradesector median 36.1% · 5,039 companies 8.0% View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View

Recent changes

  1. · Gazette deed Reappointments: IMMO & MANAGEMENT BEULS (director) and BEULS Guillaume Albert Joseph (director)Permanent representative: BEULS Philippe Norbert Denis Robert
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as PHARMACIE BEULS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.4m and €1.7m, founded between 1984 and 1991.

CompanyTotal assetsGross margin
PHARMACIE BEULS Mouscron€1.4m€0.2m
ANTOPHAR Antoing€1.6m€0.2m
APOTHEEK DE VUURTOREN Oostende€1.4m€0.2m
APOTHEEK SINT-JOZEF Olen€1.6m€0.2m
APOTHEEK VANDERSTRAETEN Gent€1.7m€0.3m
APOTHEEK VANTIEGHEM-TOUSSAINT Zwevegem€1.4m€0.3m
APOTHEEK DE RAEVE Zutendaal€1.4m€0.3m
Full comparison

Key facts about PHARMACIE BEULS

What is the company number of PHARMACIE BEULS?
The company number of PHARMACIE BEULS is 0432.602.380. The VAT number is the same number with BE in front: BE 0432.602.380.
Where is PHARMACIE BEULS based?
The registered office is at Dorpstraat(L) 7, 7700 Mouscron.Company details
What does PHARMACIE BEULS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE BEULS?
The legal form of PHARMACIE BEULS is Public limited company (NV).
When was PHARMACIE BEULS founded?
PHARMACIE BEULS was founded on 23-11-1987.
Is PHARMACIE BEULS still active?
Yes, PHARMACIE BEULS is an active enterprise in the KBO register.
How many employees does PHARMACIE BEULS have?
PHARMACIE BEULS had an average of 2.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMACIE BEULS fall under?
In its 2025 annual accounts, PHARMACIE BEULS states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of PHARMACIE BEULS?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €216,282 and 51 comparable companies (NACE 477). It probably lies between €690,000 and €2.0m.
Is PHARMACIE BEULS profitable?
In financial year 2025, PHARMACIE BEULS made a profit of €35,617.
Where can I find the annual accounts of PHARMACIE BEULS?
PHARMACIE BEULS filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE BEULS due?
PHARMACIE BEULS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.